Compounds for the treatment of Clostridium difficile-associated disease

Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.

Saved in:
Bibliographic Details
Main Authors VAN WELL RENATE, SUDLOW LAUREN JAYNE, WREN STEPHEN PAUL, JOHNSON PETER DAVID, DORGAN COLIN RICHARD, WILSON FRANCIS XAVIER, VICKERS RICHARD JOHN
Format Patent
LanguageEnglish
Published 24.03.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds of formula (I): or a pharmaceutically acceptable N-oxide, salt, hydrate, solvate, complex, bioisostere, metabolite or prodrug thereof, which are of use in the treatment of infection with, and diseases caused by, Clostridium difficile.
Bibliography:Application Number: US201213691319